Streptolysin o modulates cytokine synthesis in human peripheral blood mononuclear cells

Advances in Experimental Medicine and Biology

Volumn 418, Issue , 1997, Pages 925-927

  Stevens, D L ^a   Bryant, A E ^b  

^a Boise VA Medical Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EXOTOXIN; INTERLEUKIN 1BETA; STREPTOLYSIN O; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; HUMAN; HUMAN CELL; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INDUCTION; STREPTOCOCCUS PYOGENES;

EID: 0030770573     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1825-3_217     Document Type: Conference Paper

References (6)

1. Barsumian EL, Schlievcrt PM. Watson DW: Non-specific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun 1978;22:681-688.
2. Hackett SP, Stevens DL: Streptococcal toxic shock syndrome: Synthesis of tumor necrosis factor and interleukin-l by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis 1992;165:879-885.
3. Kim YB. Watson DW: A purified group A streptococcal pyrogenic exotoxin. Physiochcmical and biological properties including the enhancement of susceptibility to endotoxin lethal shock. J Exp Med 1970:131:611-628.
4. Stevens DL, Bryant AE, Hackett SP, et al: Group A streptococcal bacteremia: The role of tumor necrosis factor in shock and organ failure. J Infect Dis 1996; 173:619-626.
5. Stevens DL, Gibbons AE, Bergstrom R, Winn V: The Eagle effect revisited: Efficacy of clindamycin. erythromycin. and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988:158:23-28.
6. Stevens D: Streptococcal toxic shock syndrome: Spectrum of disease, pathogenesis and new concepts in treatment. Emerg Infect Dis 1995; 1:69-78.